V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002083 | 250007724 | null | null | null | 2019-10-09 | 2019-10-09 | Trial Unspecified | 02 | N | IPILIMUMAB + NIVOLUMAB | 101586927 |
| 250002086 | 250007725 | null | null | Palliative (P) | 2020-07-07 | 2020-08-13 | Paclitaxel (2 or 3 weekly) | 02 | N | IRINOTECAN + CISPLATIN + MITOMYCIN | 101535464 |
| 250002089 | 250007727 | 1.67 | 48.2 | null | 2021-12-18 | 2021-12-22 | Carboplatin + Pemetrexed | 01 | N | CISPLATIN + RT | 101537663 |
| 250002097 | 250007730 | null | null | Palliative (P) | null | 2020-06-08 | Oxaliplatin + Modified de Gramont | null | null | IMATINIB | 100513547 |
| 250002098 | 250007731 | 1.78 | 72.95 | null | 2019-08-14 | 2019-08-27 | VINCRISTINE | 02 | null | TRIAL UNSPECIFIED | 101189822 |
| 250002099 | 250007732 | null | null | Palliative (P) | 2019-08-29 | 2019-09-02 | Atezolizumab | 01 | null | DOXORUBICIN + OLARATUMAB | 100199674 |
| 250002104 | 250007734 | 1.58 | null | Curative (C) | 2019-11-15 | 2019-11-16 | CISPLATIN + FLUOROURACIL | 02 | N | ATEZOLIZUMAB | 101714991 |
| 250002120 | 250007740 | 1.64 | 92.6 | null | null | 2020-01-07 | NB BEACON Dinutuximab, Temozolomide and Topotecan | 02 | N | CAPECITABINE + OXALIPLATIN | 101504562 |
| 250002121 | 250007741 | 1.73 | 100 | Palliative (P) | 2019-06-21 | 2019-07-27 | WT Guidelines Carboplatin/Etoposide | 02 | N | PACLITAXEL | 101421269 |
| 250002123 | 250007742 | 1.71 | 91.5 | Palliative (P) | 2018-07-15 | 2018-07-23 | Atezolizumab | 02 | null | ATEZOLIZUMAB | 101069749 |
| 250002133 | 250007748 | 1.82 | 14.6 | null | 2020-10-17 | 2020-10-17 | Antibody NBL | 02 | null | CARBOPLATIN | 100542183 |
| 250002136 | 250007749 | 0 | 95.1 | Neo-adjuvant (N) | null | 2020-07-13 | Paclitaxel 7 day | 02 | N | CARBOPLATIN | 100529938 |
| 250002145 | 250007752 | 1.7 | 75 | Curative (C) | 2018-04-27 | 2018-05-28 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101472386 |
| 250002153 | 250007753 | 1.82 | 75.5 | null | 2020-04-09 | 2020-07-16 | Capecitabine (14 days)+Carboplatin | 02 | N | CARBOPLATIN + PEMETREXED | 100292841 |
| 250002156 | 250007755 | 1.62 | 87.5 | null | 2017-12-10 | 2018-01-01 | Cyclophosphamide + Topotecan | 02 | null | BEVACIZUMAB | 100604334 |
| 250002158 | 250007756 | 1.85 | 69 | null | 2018-10-01 | 2018-10-20 | null | 02 | null | BUSULFAN + MELPHALAN | 101285695 |
| 250002163 | 250007757 | 1.67 | 66 | null | 2020-02-20 | 2020-02-27 | Ifosfamide | 02 | null | ATEZOLIZUMAB | 101357085 |
| 250002169 | 250007759 | 1.68 | 71 | Curative (C) | 2021-07-02 | 2021-07-15 | Trabectedin | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 100876897 |
| 250002186 | 250007764 | 1 | 88 | null | 2018-07-25 | 2019-11-01 | null | 02 | N | TIVOZANIB | 100759721 |
| 250002188 | 250007765 | 1.76 | 70.5 | Curative (C) | 2019-06-08 | 2019-06-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CISPLATIN | 101485972 |
| 250002194 | 250007768 | 1.56 | 70.4 | null | 2021-02-18 | 2021-02-28 | null | 02 | null | DOCETAXEL | 100325175 |
| 250002197 | 250007770 | 1.7 | 71 | Palliative (P) | 2017-08-24 | 2017-08-24 | null | 02 | N | ATEZOLIZUMAB | 100828325 |
| 250002212 | 250007772 | 1.55 | 83.5 | null | 2018-04-16 | 2019-08-02 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100197493 |
| 250002215 | 250007773 | 1.67 | 10.8 | Palliative (P) | 2018-12-22 | 2018-12-29 | Cisplatin + Pemetrexed | 02 | N | CARBOPLATIN + FLUOROURACIL | 101174841 |
| 250002223 | 250007774 | 1.87 | 12.4 | null | 2017-12-28 | 2018-04-28 | Atezolizumab | 02 | Y | DACARBAZINE | 101307704 |
| 250002227 | 250007775 | null | null | null | null | 2020-02-12 | Docetaxel + Gemcitabine (prior RT) | null | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100248687 |
| 250002234 | 250007777 | 1.82 | 132 | null | 2018-10-30 | 2018-11-02 | CARBOPLATIN + FLUOROURACIL | 02 | null | DOXORUBICIN | 101705633 |
| 250002237 | 250007779 | null | null | Palliative (P) | null | 2019-10-12 | null | null | null | CABOZANTINIB | 100773104 |
| 250002239 | 250007781 | 1.82 | 106.7 | null | 2018-09-20 | 2018-09-23 | null | 02 | null | CARBOPLATIN | 101525680 |
| 250002243 | 250007783 | null | null | Palliative (P) | null | 2020-03-09 | Trial Unspecified | null | N | CAPECITABINE + IRINOTECAN | 101222663 |
| 250002245 | 250007784 | null | null | null | null | 2016-09-20 | null | null | null | CISPLATIN | 100936287 |
| 250002246 | 250007785 | 1.73 | 67.8 | Palliative (P) | null | null | EW Rel rEECur Ifosfamide | 01 | N | IMATINIB | 100136221 |
| 250002255 | 250007790 | null | null | null | 2019-06-19 | 2019-06-30 | CABOZANTINIB | 02 | N | CARBOPLATIN + PEMETREXED | 100518658 |
| 250002266 | 250007794 | null | null | Palliative (P) | 2022-04-06 | 2022-04-06 | Trial Unspecified | 02 | null | IMATINIB | 100799075 |
| 250002267 | 250007795 | 1.75 | 99.8 | null | null | 2018-06-13 | Cisplatin + Doxorubicin | 01 | N | NB HRNBL-1 COJEC IND COURSE C | 101699567 |
| 250002271 | 250007797 | 1.69 | 69.4 | null | 2016-02-08 | 2016-02-12 | Carboplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100132384 |
| 250002277 | 250007799 | null | null | null | null | 2017-12-24 | NB HRNBL-1 COJEC Ind COURSE A | null | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100267243 |
| 250002279 | 250007800 | 1.86 | 45.2 | null | 2020-02-23 | 2020-02-24 | Cisplatin + Radiotherapy | 02 | N | CARBOPLATIN + PACLITAXEL | 101420799 |
| 250002281 | 250007802 | 1.68 | 73.2 | null | null | 2017-09-14 | null | 02 | N | CAPECITABINE + CARBOPLATIN | 100043914 |
| 250002282 | 250007803 | null | null | null | null | 2017-12-17 | Carboplatin + Pemetrexed | null | null | TRIAL UNSPECIFIED | 100423959 |
| 250002286 | 250007804 | null | null | null | null | 2018-09-04 | DOXORUBICIN | null | N | TRIAL UNSPECIFIED | 100551826 |
| 250002292 | 250007806 | 0.88 | 73 | 03 | 2019-06-13 | 2019-10-07 | null | 01 | null | ENZALUTAMIDE | 101447840 |
| 250002293 | 250007807 | null | null | Neo-adjuvant (N) | 2018-03-18 | 2018-03-21 | Paclitaxel 7 day | 01 | null | ATEZOLIZUMAB | 100462395 |
| 250002305 | 250007812 | 0 | 55.8 | null | 2013-10-23 | 2013-11-03 | Atezolizumab | 01 | N | ATEZOLIZUMAB | 101639644 |
| 250002306 | 250007813 | 1.62 | 16.9 | Palliative (P) | 2018-12-01 | 2018-12-22 | null | 01 | N | CAPECITABINE + OXALIPLATIN | 101569819 |
| 250002307 | 250007814 | 1.73 | 61 | Palliative (P) | null | 2019-11-27 | Olaparib | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 101329965 |
| 250002309 | 250007816 | null | null | null | null | 2017-10-31 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 101720961 |
| 250002312 | 250007817 | null | null | Curative (C) | null | 2019-09-25 | Trial Unspecified | null | null | NB HRNBL-1 COJEC IND COURSE C | 101565576 |
| 250002313 | 250007818 | 1.01 | 99.4 | Palliative (P) | 2019-05-23 | 2019-06-07 | null | 01 | N | TRIAL UNSPECIFIED | 101535452 |
| 250002314 | 250007819 | null | null | 03 | null | 2017-10-22 | Capecitabine (21days) + Carboplatin | null | N | CARBOPLATIN | 101026921 |